Attached files
| file | filename |
|---|---|
| EX-99.2 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Clene Inc. | ea132520ex99-2_cleneinc.htm |
| EX-99.1 - PRESS RELEASE, DATED DECEMBER 30, 2019 - Clene Inc. | ea132520ex99-1_cleneinc.htm |
| EX-16.1 - LETTER TO THE SEC FROM FRIEDMAN LLP, DATED JANUARY 4, 2021 - Clene Inc. | ea132520ex16-1_cleneinc.htm |
| EX-10.4 - 2020 EQUITY INCENTIVE PLAN - Clene Inc. | ea132520ex10-4_cleneinc.htm |
| EX-3.2 - BYLAWS OF CLENE INC - Clene Inc. | ea132520ex3-2_cleneinc.htm |
| EX-3.1 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CLENE INC - Clene Inc. | ea132520ex3-1_cleneinc.htm |
| 8-K - CURRENT REPORT - Clene Inc. | ea132520-8k_cleneinc.htm |
Exhibit 21.1
Subsidiaries of Clene Inc.
| Name of Subsidiary | Jurisdiction of Organization | |
| Clene Nanomedicine, Inc. | Delaware | |
| Clene Australia Pty Ltd | Australia | |
| dOrbital, Inc. | Delaware |